Abstract |
Chemokine production by tumors is a well-known phenomenon, but its role in tumor biology remains debatable. Although intratumoral injection of granulocyte chemotactic protein-2 (GCP-2) had no effect on tumor parameters, needle-free stable expression of the chemokine resulted in enhanced tumor growth. It is shown here that tumors that express a potent form of GCP-2 induce a strong influx and activation of tumor-associated neutrophils. The production of GCP-2 leads to intratumoral expression of gelatinase B and advantage for tumor growth by increased angiogenesis. These results are in line with the countercurrent principle of chemokine action and support the notion that paraneoplastic expression of ELR-positive CXC chemokines has to be blocked rather than stimulated in cancer therapy.
|
Authors | E Van Coillie, I Van Aelst, A Wuyts, R Vercauteren, R Devos, C De Wolf-Peeters, J Van Damme, G Opdenakker |
Journal | The American journal of pathology
(Am J Pathol)
Vol. 159
Issue 4
Pg. 1405-14
(Oct 2001)
ISSN: 0002-9440 [Print] United States |
PMID | 11583968
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CXCL6 protein, human
- Chemokine CXCL6
- Chemokines, CXC
- Peptide Fragments
- Recombinant Proteins
|
Topics |
- Animals
- Chemokine CXCL6
- Chemokines, CXC
(genetics, physiology)
- Chemotaxis, Leukocyte
- Female
- Gene Transfer Techniques
- Humans
- Injections, Intralesional
- Melanoma
(blood supply, pathology, physiopathology)
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Neovascularization, Pathologic
(etiology)
- Neutrophils
(physiology)
- Peptide Fragments
(physiology)
- Recombinant Proteins
- Skin Neoplasms
(blood supply, pathology, physiopathology)
- Transfection
|